Literature DB >> 18949610

Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma.

Aliyah Rahemtullah1, Nancy Lee Harris, Michelle E Dorn, Frederic I Preffer, Robert P Hasserjian.   

Abstract

Hodgkin lymphomas are characterised by the presence of rare malignant cells in a background of non-neoplastic inflammatory cells. Flow cytometric analysis of involved tissues is generally not thought to be useful in establishing the diagnosis, because of the small number of neoplastic cells present. However, two recent studies describing a CD4+CD8+ (double-positive) T-cell population in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) suggest that flow cytometry could play a role in the diagnosis of this Hodgkin lymphoma subtype. In addition, awareness of this unusual T-cell population is important in avoiding a misdiagnosis of a T-cell neoplasm. Although the function of CD4+CD8+ T-cells in NLPHL is not known, studies of phenotypically similar cells in other settings point to a reactive or regulatory role. CD4+CD8+ T-cells have also been identified in the benign entity progressive transformation of germinal centres (PTGC), suggesting a possible relationship between NLPHL and PTGC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949610     DOI: 10.1080/10428190802308728

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C.

Authors:  Michelina Nascimbeni; Stanislas Pol; Bertrand Saunier
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

2.  Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.

Authors:  Lydia Visser; Bea Rutgers; Arjan Diepstra; Anke van den Berg; Ahmad Sattarzadeh
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

3.  Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus.

Authors:  Yongkang Wu; Bei Cai; Weihua Feng; Bin Yang; Zhuochun Huang; Chuan Zuo; Lanlan Wang
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.